SS Innovations Announces Successful Completion of First Robotic Telesurgery Performed from the Company’s MantraM Mobile Robotic Telesurgery Unit
SS Innovations (NASDAQ:SSII) has achieved a significant milestone in telemedicine with the successful completion of the first robotic telesurgery performed from their MantraM mobile robotic telesurgery unit. Dr. Priya Bhave Chittawar conducted a complex hysterectomy remotely from the MantraM bus, connecting to an operating room at HER Health in Bhopal, India, using the company's SSi Mantra surgical robotic system.
The achievement demonstrates the company's progress in making advanced surgical care accessible to underserved communities. The MantraM bus, which began its tour across India in July 2025, serves dual purposes: bringing specialized care to remote locations and providing surgical robotic education to medical professionals. The mobile unit has been visiting hospitals, clinics, conferences, and medical colleges in India's underserved regions.
SS Innovations (NASDAQ:SSII) ha raggiunto un importante traguardo nella telemedicina completando con successo la prima telesurgeria robotica eseguita dal suo unità mobile robotica MantraM. La dottoressa Priya Bhave Chittawar ha eseguito da remoto una complessa isterectomia dal bus MantraM, collegandosi a una sala operatoria presso HER Health a Bhopal, India, mediante il sistema chirurgico robotico SSi Mantra dell’azienda.
Questo risultato testimonia i progressi nella diffusione di cure chirurgiche avanzate verso comunità svantaggiate. Il bus MantraM, in tournée in India da luglio 2025, ha una doppia missione: portare cure specialistiche nelle aree più remote e offrire formazione all’uso della chirurgia robotica ai professionisti sanitari. L’unità mobile sta visitando ospedali, cliniche, convegni e facoltà di medicina nelle regioni meno servite del Paese.
SS Innovations (NASDAQ:SSII) ha alcanzado un hito importante en telemedicina al completar con éxito la primera telescirugía robótica realizada desde su unidad móvil robótica MantraM. La Dra. Priya Bhave Chittawar realizó de forma remota una histerectomía compleja desde el autobús MantraM, conectándose con un quirófano de HER Health en Bhopal, India, mediante el sistema quirúrgico robótico SSi Mantra de la compañía.
Este logro demuestra el avance de la empresa en hacer accesible la atención quirúrgica avanzada a comunidades desfavorecidas. El bus MantraM, que inició su gira por India en julio de 2025, cumple una doble función: llevar atención especializada a zonas remotas y ofrecer formación en robótica quirúrgica a profesionales médicos. La unidad móvil está visitando hospitales, clínicas, congresos y facultades de medicina en las regiones menos atendidas del país.
SS Innovations (NASDAQ:SSII)는 자사의 MantraM 모바일 로봇 원격수술 유닛에서 첫 로봇 원격수술을 성공적으로 완료하며 원격의료 분야에서 중요한 성과를 달성했습니다. 프리야 바브 채타와르(Dr. Priya Bhave Chittawar) 박사는 MantraM 버스에서 원격으로 복잡한 자궁적출술을 집도했으며, 회사의 SSi Mantra 수술 로봇 시스템을 통해 인도 보팔의 HER Health 수술실과 연결했습니다.
이번 성과는 소외된 지역사회에도 첨단 외과 치료를 제공하려는 회사의 진전을 보여줍니다. 2025년 7월 인도 투어를 시작한 MantraM 버스는 원격지역에 전문진료를 제공하는 것과 의료진을 대상으로 수술 로봇 교육을 실시하는 두 가지 목적을 수행합니다. 이 모바일 유닛은 인도의 의료 취약 지역에 있는 병원, 클리닉, 학회 및 의과대학을 방문하고 있습니다.
SS Innovations (NASDAQ:SSII) a franchi une étape importante en télémédecine en réussissant la première téléchirurgie robotique effectuée depuis son unité mobile robotique MantraM. La Dre Priya Bhave Chittawar a réalisé à distance une hystérectomie complexe depuis le bus MantraM, en se connectant à une salle d'opération de HER Health à Bhopal, en Inde, grâce au système chirurgical robotique SSi Mantra de la société.
Cette réussite illustre les progrès de l'entreprise pour rendre les soins chirurgicaux avancés accessibles aux communautés défavorisées. Le bus MantraM, qui a entamé sa tournée en Inde en juillet 2025, a une double vocation : apporter des soins spécialisés dans les zones reculées et dispenser une formation à la chirurgie robotique aux professionnels de santé. L'unité mobile visite hôpitaux, cliniques, salons et facultés de médecine dans les régions les moins bien desservies du pays.
SS Innovations (NASDAQ:SSII) hat einen bedeutenden Meilenstein in der Telemedizin erreicht: die erfolgreiche Durchführung der ersten robotergestützten Teleschirurgie aus seiner mobilen Robotik-Einheit MantraM. Dr. Priya Bhave Chittawar führte eine komplexe Hysterektomie remote vom MantraM-Bus aus durch und verband sich dabei mit einem OP-Saal von HER Health in Bhopal, Indien, mittels des chirurgischen Robotersystems SSi Mantra des Unternehmens.
Dieser Erfolg zeigt den Fortschritt des Unternehmens, fortschrittliche chirurgische Versorgung für benachteiligte Gemeinschaften zugänglich zu machen. Der MantraM-Bus, der seit Juli 2025 durch Indien tourt, erfüllt zwei Aufgaben: spezialisierte Versorgung in entlegene Gebiete zu bringen und medizinisches Personal in robotischer Chirurgie auszubilden. Die mobile Einheit besucht Krankenhäuser, Kliniken, Konferenzen und medizinische Hochschulen in den unterversorgten Regionen Indiens.
- Successfully completed first remote robotic telesurgery from mobile unit
- Mobile platform enables delivery of specialized surgical care to underserved areas
- System facilitates medical training and education in remote locations
- Technology helps overcome traditional cost and distance barriers in healthcare
- None.
Insights
SS Innovations demonstrates breakthrough mobile telesurgery capabilities, advancing their mission of democratizing robotic surgery access globally.
This successful demonstration of mobile robotic telesurgery represents a significant technological milestone for SS Innovations. The ability to perform complex procedures like hysterectomies remotely from their MantraM mobile unit potentially solves two critical healthcare barriers simultaneously: geographical limitations and cost accessibility.
The technical achievement here shouldn't be understated. Remote robotic surgery requires extraordinarily precise data transmission with minimal latency, robust connectivity protocols, and fail-safe mechanisms. By successfully executing this procedure, SS Innovations has demonstrated their platform's reliability in real-world conditions outside controlled hospital environments.
What's particularly notable is the market positioning strategy. While competitors in the surgical robotics space typically focus on selling high-cost systems to major medical centers, SS Innovations is pursuing a different approach by explicitly targeting underserved communities. Their ongoing MantraM bus tour across India reinforces this strategy by bringing demonstrations directly to hospitals, clinics, and medical colleges in regions lacking advanced surgical options.
The combination of mobile capabilities and telesurgery effectively creates a hub-and-spoke model where surgical expertise can be projected anywhere the MantraM unit can travel, potentially multiplying the impact of each specialist surgeon and robotic system. This could significantly expand the addressable market by making specialized surgical care viable in areas previously considered impractical for advanced robotic systems.
Marks another milestone in the Company’s mission to bring advanced surgical robotic care to underserved patient populations
FORT LAUDERDALE, Fla., Sept. 09, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced the successful completion of the first robotic telesurgery performed from the Company’s MantraM mobile robotic telesurgery unit (the “MantraM bus”). Dr. Priya Bhave Chittawar, Founder and Managing Director of Harmony Institute of Excellence in Reproductive Health (“HER Health”), guided a complex hysterectomy remotely from the MantraM bus utilizing the Company’s SSi Mantra surgical robotic system and seamlessly connecting to an operating room at HER Health in Bhopal, India.
Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer of SS Innovations, commented, “We believe that our advanced, cost-efficient SSi Mantra surgical robotic system, proven telesurgery capabilities, and state-of-the-art MantraM mobile unit affords the ability to overcome traditional cost and distance hurdles, thereby enabling delivery of world-class surgical care to underserved patient communities. We are grateful for the support of the HER Health team and Dr. Chittawar, who successfully carried out the first robotic telesurgery performed from our MantraM bus, marking another important milestone in our mission to democratize access to top-tier surgical robotic care and expertise. The MantraM bus is designed to not only bring specialized care to patients in remote settings but also to facilitate immersive surgical robotic education and training for a wider range of physicians and other medical professionals regardless of their location.”
In July 2025, SS Innovations launched a MantraM bus tour across India to showcase the capabilities of its mobile robotic telesurgery unit and the SSi Mantra surgical robotic system. The tour has focused on visits to and demonstrations at hospitals, clinics, conferences, and medical colleges in India’s underserved communities.
About SS Innovations
SS Innovations International, Inc. (Nasdaq: SSII) develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The Company’s product range includes its proprietary “SSi Mantra” surgical robotic system and its comprehensive suite of “SSi Mudra” surgical instruments, which support a variety of surgical procedures including robotic cardiac surgery. An American company headquartered in India, SS Innovations plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. Visit the Company’s website at ssinnovations.com or LinkedIn for more information and updates.
About the SSi Mantra
The SSi Mantra surgical robotic system is a user-friendly, modular, multi-arm system with many advanced technology features, including: 3 to 5 modular robotic arms, an open-faced ergonomic surgeon command center, a large 3D 4K monitor, a touch panel monitor for all patient related information display, a virtual real-time image of the robotic patient side arm carts, and the ability for superimposition of 3D models of diagnostic imaging. A vision cart provides the table-side team with the same magnified 3D 4K view as the surgeon to provide better safety and efficiency. The SSi Mantra utilizes over 40 different types of robotic endo-surgical instruments to support different specialties, including cardiac surgery. The SSi Mantra has been clinically validated in India in more than 100 different types of surgical procedures.
Forward Looking Statements
This press release may contain statements that are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. The words “anticipate,” “assume,” “believe,” “estimate,” “expect,” “will,” “intend,” “may,” “plan,” “project,” “should,” “could,” “seek,” “designed,” “potential,” “forecast,” “target,” “objective,” “goal,” or the negatives of such terms or other similar expressions to identify such forward-looking statements. These statements relate to future events or SS Innovations’ future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.
Investor Contact:
The Equity Group
Kalle Ahl, CFA
T: (303) 953-9878
kahl@theequitygroup.com
Devin Sullivan, Managing Director
T: (212) 836-9608
dsullivan@theequitygroup.com
Media Contact:
RooneyPartners LLC
Kate Barrette
T: (212) 223-0561
kbarrette@rooneypartners.com
Photos accompanying this announcement are available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/2f41b610-1607-49fa-b4cc-45696a993061
https://www.globenewswire.com/NewsRoom/AttachmentNg/c8e4feba-8430-4631-ad24-85824db6cf6c
